|
WO1989006162A1
(en)
*
|
1988-01-04 |
1989-07-13 |
Oncotech Incorporated |
Methods and apparatus assessing tumor resistance
|
|
US5366885A
(en)
*
|
1992-06-09 |
1994-11-22 |
Barranco Iii Sam C |
Method and kit for testing tumors for drug sensitivity
|
|
US5474909A
(en)
*
|
1992-08-07 |
1995-12-12 |
Anticancer, Inc. |
Noncolorimetric histoculture method for predicting drug response of tumors
|
|
WO1996022085A1
(en)
*
|
1995-01-17 |
1996-07-25 |
Pfizer Inc. |
The use of sertraline to treat cancer patients
|
|
US6825174B2
(en)
*
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
US5736129A
(en)
*
|
1995-11-17 |
1998-04-07 |
Medenica; Rajko D. |
Flow cytometric pharmacosensitivity assay and method of cancer treatment
|
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
WO1997045105A1
(en)
*
|
1996-05-24 |
1997-12-04 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing diseases of body passageways
|
|
US8828432B2
(en)
*
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
US7026447B2
(en)
*
|
1997-10-09 |
2006-04-11 |
Human Genome Sciences, Inc. |
53 human secreted proteins
|
|
US20030049618A1
(en)
*
|
1997-03-07 |
2003-03-13 |
Ruben Steven M. |
186 human secreted proteins
|
|
US20030059471A1
(en)
*
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
US6207717B1
(en)
*
|
1999-01-12 |
2001-03-27 |
Dow Corning Corporation |
Entrapment of vitamins with an elastomeric silicone polyether
|
|
US6890904B1
(en)
*
|
1999-05-25 |
2005-05-10 |
Point Therapeutics, Inc. |
Anti-tumor agents
|
|
US6911306B1
(en)
*
|
1999-10-18 |
2005-06-28 |
Emory University |
TMS1 compositions and methods of use
|
|
WO2001032677A1
(en)
*
|
1999-11-04 |
2001-05-10 |
Human Genome Sciences, Inc. |
Uteroglobin-like polynucleotides, polypeptides, and antibodies
|
|
US6448030B1
(en)
*
|
2000-02-18 |
2002-09-10 |
University Of Nevada-Las Vegas |
Method for predicting the efficacy of anti-cancer drugs
|
|
US7723303B2
(en)
*
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
AU2002220265A1
(en)
*
|
2000-11-03 |
2002-05-15 |
University Of Vermont And State Agricultural College |
Compositions for inhibiting grb7
|
|
WO2002046750A2
(en)
*
|
2000-11-13 |
2002-06-13 |
Vanderbilt University |
Methods of predicting chemotherapy response
|
|
US20050013853A1
(en)
*
|
2000-11-29 |
2005-01-20 |
Irit Gil-Ad |
Anti-proliferative drugs
|
|
IL139975A0
(en)
*
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
DE10064997A1
(en)
*
|
2000-12-23 |
2002-06-27 |
Merck Patent Gmbh |
New 1-benzoyl-3-phenyl-tetrahydropyridazine derivatives, useful for treating e.g. allergy, are selective inhibitors of phosphodiesterase IV, and new intermediates
|
|
IL156460A0
(en)
*
|
2001-01-31 |
2004-01-04 |
Pfizer Prod Inc |
Ether derivatives useful as inhibitors of pde4 isozymes
|
|
WO2002062792A1
(en)
*
|
2001-02-02 |
2002-08-15 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
|
ATE412893T1
(en)
*
|
2001-02-14 |
2008-11-15 |
Evotec Ag |
DISPENSION DEVICE
|
|
JP4634694B2
(en)
*
|
2001-03-23 |
2011-02-16 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
Fatty alcohol drug complex
|
|
US20070021360A1
(en)
*
|
2001-04-24 |
2007-01-25 |
Nyce Jonathan W |
Compositions, formulations and kit with anti-sense oligonucleotide and anti-inflammatory steroid and/or obiquinone for treatment of respiratory and lung disesase
|
|
US20040072824A1
(en)
*
|
2001-06-01 |
2004-04-15 |
Adam Telerman |
Methods and compositions for the treatment of cancer
|
|
US7355042B2
(en)
*
|
2001-10-16 |
2008-04-08 |
Hypnion, Inc. |
Treatment of CNS disorders using CNS target modulators
|
|
CA2466138A1
(en)
*
|
2001-11-02 |
2003-05-15 |
Shen Wu Wang |
B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
|
|
US20040072181A1
(en)
*
|
2002-01-22 |
2004-04-15 |
Whitehead Alexander Steven |
Methods for determining drug responsiveness
|
|
GB0202337D0
(en)
*
|
2002-02-01 |
2002-03-20 |
Univ Birmingham |
Cancer treatment
|
|
GB0203276D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Novartis Ag |
Organic compounds
|
|
DE10214388A1
(en)
*
|
2002-03-30 |
2003-10-16 |
Cognis Deutschland Gmbh |
Process for the production of solid materials
|
|
WO2003102158A2
(en)
*
|
2002-05-31 |
2003-12-11 |
The Forsyth Institute |
Methods for increasing bone density
|
|
AU2003265264A1
(en)
*
|
2002-07-09 |
2004-01-23 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
|
CN1389462A
(en)
*
|
2002-07-12 |
2003-01-08 |
复旦大学 |
Grandifoliate burchellin and its homologue and application in preparing composite medicine
|
|
US20060009378A1
(en)
*
|
2002-11-14 |
2006-01-12 |
Itshak Golan |
Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
|
|
US20040101477A1
(en)
*
|
2002-11-27 |
2004-05-27 |
Xanthus Life Sciences, Inc. |
Individualization of therapy with anesthetics
|
|
WO2004091572A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Biodelivery Sciences International, Inc. |
Cochleate compositions directed against expression of proteins
|
|
EP1624858B1
(en)
*
|
2003-04-09 |
2018-06-06 |
Rutgers, the State University of New Jersey |
Novel encochleation methods
|
|
US7329638B2
(en)
*
|
2003-04-30 |
2008-02-12 |
The Regents Of The University Of Michigan |
Drug delivery compositions
|
|
US20050136043A1
(en)
*
|
2003-08-07 |
2005-06-23 |
Ludwig Institute For Cancer Research |
TGFbeta signaling inhibitors
|
|
SE0302232D0
(en)
*
|
2003-08-18 |
2003-08-18 |
Astrazeneca Ab |
Novel Compounds
|
|
WO2005020933A2
(en)
*
|
2003-09-02 |
2005-03-10 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
WO2005081687A2
(en)
*
|
2003-09-30 |
2005-09-09 |
Centocor, Inc. |
Human hinge core mimetibodies, compositions, methods and uses
|
|
US20050143378A1
(en)
*
|
2003-12-29 |
2005-06-30 |
Yun Anthony J. |
Treatment of conditions through pharmacological modulation of the autonomic nervous system
|
|
US9173847B2
(en)
*
|
2003-10-10 |
2015-11-03 |
Veloxis Pharmaceuticals A/S |
Tablet comprising a fibrate
|
|
EP1691891A2
(en)
*
|
2003-11-13 |
2006-08-23 |
The Board Of Regents, The University Of Texas System |
Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure
|
|
US7211275B2
(en)
*
|
2004-01-16 |
2007-05-01 |
Massachusetts Institute Of Technology |
Composite materials for controlled release of water soluble products
|
|
US20070166363A1
(en)
*
|
2004-02-19 |
2007-07-19 |
Lane Roger M |
Use of cholinesterase inhibitors for treating vascular depression
|
|
EP1746976B1
(en)
*
|
2004-05-03 |
2017-01-11 |
Merrimack Pharmaceuticals, Inc. |
Liposomes useful for drug delivery
|
|
US8529889B2
(en)
*
|
2004-06-29 |
2013-09-10 |
Massachusetts Institute Of Technology |
Methods and compositions related to the modulation of intercellular junctions
|
|
US20060009506A1
(en)
*
|
2004-07-09 |
2006-01-12 |
Odyssey Thera, Inc. |
Drugs for the treatment of neoplastic disorders
|
|
ES2341559T3
(en)
*
|
2004-07-23 |
2010-06-22 |
The Medicines Company (Leipzig) Gmbh |
PIRIDO (3 ', 2': 4,5) HAVING (3,2-D) PYRIMIDINES AND PIRIDO (3 ', 2': 4,5) FURO (3,2-D) PIRIMIDINES REPLACED FOR USE AS INHIBITORS OF THE RELEASE OF PDA-4 AND / OR TNF-ALFA.
|
|
US7566548B2
(en)
*
|
2004-08-13 |
2009-07-28 |
University Of Massachusetts |
Methods for identifying therapeutic agents and for treating disease
|
|
US20060039975A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Zalman Vilkov |
Paroxetine formulations
|
|
EP1627610A1
(en)
*
|
2004-08-21 |
2006-02-22 |
TLT Medical Ltd |
Drug delivery throug application in nails
|
|
US7393662B2
(en)
*
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
EP1792519A4
(en)
*
|
2004-09-10 |
2010-09-15 |
Otologics Llc |
Adjustable bone bracket
|
|
US20060058966A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Bruckner Howard W |
Methods and systems for guiding selection of chemotherapeutic agents
|
|
US20060062734A1
(en)
*
|
2004-09-20 |
2006-03-23 |
Melker Richard J |
Methods and systems for preventing diversion of prescription drugs
|
|
JP2008514612A
(en)
*
|
2004-09-23 |
2008-05-08 |
ミシャロウ、アレクサンダー |
Methods of modulating neurotransmitter systems by inducing counter adaptation
|
|
EP2444071A1
(en)
*
|
2004-09-27 |
2012-04-25 |
Sigmoid Pharma Limited |
Minicapsule formulations
|
|
US20090011410A1
(en)
*
|
2004-10-20 |
2009-01-08 |
Masato Mitsuhashi |
Method for tailoring administration of drugs by quantitation of mrna
|
|
DE602005011844D1
(en)
*
|
2004-11-02 |
2009-01-29 |
Pfizer |
SULFONYLBENZIMIDAZOLDERIVATE
|
|
US20090082304A1
(en)
*
|
2004-11-12 |
2009-03-26 |
Northwestern University |
Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs
|
|
US20080096872A1
(en)
*
|
2004-12-22 |
2008-04-24 |
Friedman Robert S |
Composition for Treatment of Pain Specification
|
|
CA2594505A1
(en)
*
|
2005-02-01 |
2006-08-10 |
Icagen, Inc. |
Imines as ion channel modulators
|
|
CN1834659A
(en)
*
|
2005-03-17 |
2006-09-20 |
希森美康株式会社 |
Sample analyzer and sample analyzing method
|
|
WO2007053189A2
(en)
*
|
2005-06-01 |
2007-05-10 |
Northwestern University |
Compositions and methods for altering immune function
|
|
US7655421B2
(en)
*
|
2005-06-17 |
2010-02-02 |
Ciencia, Inc. |
Cytometer on a chip
|
|
HUE042561T2
(en)
*
|
2005-06-30 |
2019-07-29 |
Janssen Biotech Inc |
Anti-IL-23 antibodies, compositions, methods and uses
|
|
US20090118288A1
(en)
*
|
2005-07-21 |
2009-05-07 |
Astrazeneca Ab |
N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor
|
|
WO2007015926A2
(en)
*
|
2005-07-25 |
2007-02-08 |
Oregon Health And Science University |
Multiparameter flow cytometric cytometric cytotoxicity systems, methods, compositions and kits for evaluating the susceptibility of cancer
|
|
AR058071A1
(en)
*
|
2005-10-03 |
2008-01-23 |
Astrazeneca Ab |
DERIVATIVES OF DIHYDROPIRAZOLO (3,4-E) (1,4) DIAZEPINA. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
|
|
EP1931798A1
(en)
*
|
2005-10-05 |
2008-06-18 |
AstraZeneca UK Limited |
Method to predict or monitor the response of a patient to an erbb receptor drug
|
|
US20080318252A1
(en)
*
|
2007-04-23 |
2008-12-25 |
Scott Kachlany |
Rapid assay to test anti-cancer drugs under physiological conditions
|
|
EA200801145A1
(en)
*
|
2005-12-02 |
2008-10-30 |
Пфайзер Лимитед |
SPYROCYCLIC DERIVATIVES OF HINAZOLIN AS PDE7 INHIBITORS
|
|
US20070178165A1
(en)
*
|
2005-12-15 |
2007-08-02 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for parenteral administration
|
|
AU2007223560A1
(en)
*
|
2006-03-01 |
2007-09-13 |
Tristrata, Inc. |
Composition and method for topical treatment of tar-responsive dermatological disorders
|
|
DE602007009807D1
(en)
*
|
2006-03-06 |
2010-11-25 |
Raqualia Pharma Inc |
SULFONYLBENZIMIDAZOLDERIVATE
|
|
EP1996551A2
(en)
*
|
2006-03-07 |
2008-12-03 |
AstraZeneca AB |
Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them.
|
|
US20090029958A1
(en)
*
|
2006-03-08 |
2009-01-29 |
Lilian Alcaraz |
Phenethanolamine derivatives as beta2 adrenoreceptor agonists
|
|
TW200808763A
(en)
*
|
2006-05-08 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds I
|
|
EP2032983A2
(en)
*
|
2006-05-24 |
2009-03-11 |
Cellumen, Inc. |
Method for modeling a disease
|
|
TW200815469A
(en)
*
|
2006-06-23 |
2008-04-01 |
Astrazeneca Ab |
Compounds
|
|
CN101511775A
(en)
*
|
2006-06-29 |
2009-08-19 |
詹森药业有限公司 |
Butyl and butynyl benzyl amine compounds
|
|
CA2659655A1
(en)
*
|
2006-08-08 |
2008-02-21 |
Alan M. Fogelman |
Salicylanilides enhance oral delivery of therapeutic peptides
|
|
US20080066739A1
(en)
*
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
ME02829B
(en)
*
|
2006-09-26 |
2018-01-20 |
Celgene Corp |
5-substituted quinazolinone derivatives as anti-cancer agents
|
|
US8841300B2
(en)
*
|
2006-10-02 |
2014-09-23 |
Jerry M. Held |
Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor
|
|
EP2078016B1
(en)
*
|
2006-10-19 |
2012-02-01 |
Signal Pharmaceuticals LLC |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith
|
|
US7661326B2
(en)
*
|
2006-10-26 |
2010-02-16 |
Beckman Coulter, Inc. |
Apparatus for aspirating and dispensing liquids in an automated analyzer
|
|
TW200825084A
(en)
*
|
2006-11-14 |
2008-06-16 |
Astrazeneca Ab |
New compounds 521
|
|
GB0625322D0
(en)
*
|
2006-12-19 |
2007-01-24 |
Pharmakodex Ltd |
Pharmaceutical compositions
|
|
CN101677957A
(en)
*
|
2007-02-05 |
2010-03-24 |
卡比兰生物外科公司 |
The polymer formulations that is used for delivery of bioactive agents
|
|
GB0704000D0
(en)
*
|
2007-03-01 |
2007-04-11 |
Astrazeneca Ab |
Salts 670
|
|
AU2008222745A1
(en)
*
|
2007-03-07 |
2008-09-12 |
Janssen Pharmaceutica N.V. |
Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
|
|
GB0707127D0
(en)
*
|
2007-04-13 |
2007-05-23 |
Zysis Ltd |
Pharmaceutical compositions
|
|
US20090004281A1
(en)
*
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
US7943658B2
(en)
*
|
2007-07-23 |
2011-05-17 |
Bristol-Myers Squibb Company |
Indole indane amide compounds useful as CB2 agonists and method
|
|
SI2200588T1
(en)
*
|
2007-09-25 |
2019-08-30 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
|
US8354417B2
(en)
*
|
2007-09-26 |
2013-01-15 |
Celgene Corporation |
Solid forms comprising 3-(2,5-dimethyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same
|
|
WO2009051238A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Riken |
Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
|
|
US20090124675A1
(en)
*
|
2007-10-19 |
2009-05-14 |
Burnham Institute For Medical Research |
Inhibitors of anti-apoptotic proteins
|
|
CN101896068A
(en)
*
|
2007-10-19 |
2010-11-24 |
伯恩哈姆医学研究协会 |
The naphthyl inhibitor of anti-apoptotic proteins
|
|
EP2249806A2
(en)
*
|
2008-01-08 |
2010-11-17 |
Sirtris Pharmaceuticals, Inc. |
Resveratrol formulations
|
|
CA2721065C
(en)
*
|
2008-05-27 |
2016-09-27 |
Astrazeneca Ab |
Phenoxypyridinylamide derivatives and their use as pde4 inhibitors
|
|
EP2304436A1
(en)
*
|
2008-07-10 |
2011-04-06 |
Nodality, Inc. |
Methods for diagnosis, prognosis and treatment
|
|
TWI453207B
(en)
*
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
Aminotriazolopyridines, compositions thereof, and methods of treatment therewith
|
|
US20100099109A1
(en)
*
|
2008-10-17 |
2010-04-22 |
Nodality, Inc., A Delaware Corporation |
Methods for Analyzing Drug Response
|
|
KR101046883B1
(en)
*
|
2008-11-19 |
2011-07-06 |
재단법인 아산사회복지재단 |
How to collectively determine sensitivity to anticancer drugs
|